SCHEMBL17290974

SCHEMBL17290974

COC(=O)c1ccc(C2=NN(C)C(=O)C2C)cc1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SETD7 Q8WTS6 1/20 0.44
ALDH1A1 P00352 4/20 0.44
HPGD P15428 1/20 0.44
SMN1; SMN2 Q16637 1/20 0.44
MAPK1 P28482 1/20 0.43
ADORA2A P29274 1/20 0.42
ADORA2B P29275 1/20 0.42
KDM4E B2RXH2 2/20 0.41
CA1 P00915 3/20 0.41
CA2 P00918 3/20 0.41
CA12 O43570 2/20 0.41
CA9 Q16790 2/20 0.41
CA14 Q9ULX7 2/20 0.41
TDP1 Q9NUW8 1/20 0.41
CA7 P43166 1/20 0.41
TSHR P16473 1/20 0.40
HSD17B10 Q99714 1/20 0.40
TNKS O95271 1/20 0.40
PDE4A P27815 1/20 0.40
PDE4B Q07343 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17295079 1.00 SETD7 (0.44) SETD7ALDH1A1HPGDSMN1; SMN2MAPK1
SCHEMBL17295288 0.83 SETD7 (0.43) SETD7ALDH1A1HPGDSMN1; SMN2MAPK1
SCHEMBL17290925 0.82 ALDH1A1 (0.42) SETD7ALDH1A1HPGDSMN1; SMN2MAPK1
SCHEMBL17295295 0.82 ALDH1A1 (0.42) SETD7ALDH1A1HPGDSMN1; SMN2MAPK1
SCHEMBL17290421 0.79 SETD7 (0.42) SETD7ALDH1A1HPGDSMN1; SMN2MAPK1
SCHEMBL19387238 0.70 CA1 (0.70) SETD7ALDH1A1KDM4ECA1CA2
Biphenyl Dimethyl Dicarboxylate SCHEMBL68521 0.70 CA1 (0.70) SETD7ALDH1A1KDM4ECA1CA2
Biphenyl Dimethyl Dicarboxylate SCHEMBL2890577 0.68 CA1 (0.67) SETD7ALDH1A1KDM4ECA1CA2
SCHEMBL28993944 0.68 CA1 (0.80) ALDH1A1HPGDMAPK1KDM4ECA1
SCHEMBL23600 0.68 CA1 (0.80) ALDH1A1HPGDMAPK1KDM4ECA1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9682938-B2 Pyrazolone derivatives as nitroxyl donors CARDIOXYL PHARMACEUTICALS, INC. (US) 2017-06-20 US disclosed
EP-3148972-A1 PYRAZOLONE DERIVATIVES AS NITROXYL DONORS Cardioxyl Pharmaceuticals Inc. (US) 2017-04-05 EP disclosed
WO-2015183839-A1 PYRAZOLONE DERIVATIVES AS NITROXYL DONORS CARDIOXYL PHARMACEUTICALS, INC. (US) 2015-12-03 WO disclosed
US-20150344437-A1 PYRAZOLONE DERIVATIVES AS NITROXYL DONORS THE JOHNS HOPKINS UNIVERSITY 2015-12-03 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20150344437-A1 PYRAZOLONE DERIVATIVES AS NITROXYL DONORS TNNI3, PFKP, NOX5 SETD7 3862/4885ALDH1A1 1883/4885HPGD 19/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.